| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Age-adapted definition of chronic kidney disease based on Chronic Kidney Disease Epidemiology Collaboration and full age spectrum equation
|
Ren, Qidong
|
|
|
98 |
5 |
p. 1350-1352
|
article
|
| 2 |
A new player in the kidney–bone axis: regulation of fibroblast growth factor-23 by renal glycerol-3-phosphate
|
Massy, Ziad A.
|
|
|
98 |
5 |
p. 1074-1076
|
article
|
| 3 |
Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?
|
Noris, Marina
|
|
|
98 |
5 |
p. 1084-1087
|
article
|
| 4 |
Candida crescents in a renal allograft
|
Turner, Michael P.
|
|
|
98 |
5 |
p. 1356
|
article
|
| 5 |
Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease
|
Patino, Edwin
|
|
|
98 |
5 |
p. 1210-1224
|
article
|
| 6 |
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome
|
Jia, Xiaoyuan
|
|
|
98 |
5 |
p. 1308-1322
|
article
|
| 7 |
Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology Society
|
Haas, Mark
|
|
|
98 |
5 |
p. 1120-1134
|
article
|
| 8 |
Corrigendum to “Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability.” Kidney Int. 2003;63:1934–1943
|
|
|
|
98 |
5 |
p. 1354
|
article
|
| 9 |
Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury
|
Guyonnet, Léa
|
|
|
98 |
5 |
p. 1193-1209
|
article
|
| 10 |
Derivation and validation of genome-wide polygenic score for urinary tract stone diagnosis
|
Paranjpe, Ishan
|
|
|
98 |
5 |
p. 1323-1330
|
article
|
| 11 |
Does metformin do more benefit or harm in chronic kidney disease patients?
|
De Broe, Marc E.
|
|
|
98 |
5 |
p. 1098-1101
|
article
|
| 12 |
Editorial Board
|
|
|
|
98 |
5 |
p. A5
|
article
|
| 13 |
English–Latin nomenclature conundrum: should we use kidneylogy, kidneylogist?
|
Bover, Jordi
|
|
|
98 |
5 |
p. 1352-1353
|
article
|
| 14 |
Gastrointestinal potassium binding in hemodialysis
|
Palmer, Biff F.
|
|
|
98 |
5 |
p. 1095-1097
|
article
|
| 15 |
Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease
|
Shao, Lina
|
|
|
98 |
5 |
p. 1225-1241
|
article
|
| 16 |
Genetic variation in claudin-2, hypercalciuria, and kidney stones
|
Gillion, Valentine
|
|
|
98 |
5 |
p. 1076-1078
|
article
|
| 17 |
Global transcriptomic changes occur in aged mouse podocytes
|
Wang, Yuliang
|
|
|
98 |
5 |
p. 1160-1173
|
article
|
| 18 |
“Green/apple-green birefringence”: unfit for purpose?
|
Howie, Alexander J.
|
|
|
98 |
5 |
p. 1350
|
article
|
| 19 |
How to interpret an estimated glomerular filtration rate (eGFR) in 2020?
|
De Broe, Marc
|
|
|
98 |
5 |
p. 1090-1092
|
article
|
| 20 |
Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease
|
Ponticelli, Claudio
|
|
|
98 |
5 |
p. 1149-1159
|
article
|
| 21 |
Identifying donors with no recovery of kidney function
|
van Londen, Marco
|
|
|
98 |
5 |
p. 1349-1350
|
article
|
| 22 |
International Society of Nephrology’s initiative on interventional nephrology minimum training and program-building standards in resource-limited countries
|
Vachharajani, Tushar J.
|
|
|
98 |
5 |
p. 1067-1070
|
article
|
| 23 |
In This Issue
|
|
|
|
98 |
5 |
p. 1061
|
article
|
| 24 |
Journal Club
|
|
|
|
98 |
5 |
p. 1071-1073
|
article
|
| 25 |
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
|
Porta, Camillo
|
|
|
98 |
5 |
p. 1108-1119
|
article
|
| 26 |
Kidney International 60th anniversary edition: transplantation—the chosen 5
|
Wong, Germaine
|
|
|
98 |
5 |
p. 1064-1066
|
article
|
| 27 |
Low-dose L-NAME induces salt sensitivity associated with sustained increased blood volume and sodium-chloride cotransporter activity in rodents
|
Wang, Conghui
|
|
|
98 |
5 |
p. 1242-1252
|
article
|
| 28 |
Metformin in chronic kidney disease: a strong dose of caution
|
Hanna, Ramy M.
|
|
|
98 |
5 |
p. 1101-1105
|
article
|
| 29 |
Metformin—to use or not to use . . . is that the question?
|
Nangaku, Masaomi
|
|
|
98 |
5 |
p. 1105-1107
|
article
|
| 30 |
Moore’s law for membranous nephropathy
|
Hayashi, Norifumi
|
|
|
98 |
5 |
p. 1081-1084
|
article
|
| 31 |
Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome
|
Zhang, Yuzhou
|
|
|
98 |
5 |
p. 1265-1274
|
article
|
| 32 |
Partial lipoatrophy in dense deposit disease
|
Natarajan, Gopalakrishnan
|
|
|
98 |
5 |
p. 1355
|
article
|
| 33 |
Phasor approach to autofluorescence lifetime imaging FLIM can be a quantitative biomarker of chronic renal parenchymal injury
|
Ranjit, Suman
|
|
|
98 |
5 |
p. 1341-1346
|
article
|
| 34 |
Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties
|
Fakhouri, Fadi
|
|
|
98 |
5 |
p. 1135-1148
|
article
|
| 35 |
Providing care for patients with kidney failure over the next decade
|
Harris, David C.H.
|
|
|
98 |
5 |
p. 1062-1063
|
article
|
| 36 |
Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
|
Braun, Fabian
|
|
|
98 |
5 |
p. 1092-1094
|
article
|
| 37 |
Regarding “Derivation and validation of genome-wide polygenic score for urinary tract stone diagnosis”
|
Geraghty, Robert M.
|
|
|
98 |
5 |
p. 1347
|
article
|
| 38 |
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
|
Werion, Alexis
|
|
|
98 |
5 |
p. 1296-1307
|
article
|
| 39 |
Semaphorin 3B–associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients
|
Sethi, Sanjeev
|
|
|
98 |
5 |
p. 1253-1264
|
article
|
| 40 |
Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome
|
Liu, Xiaochen
|
|
|
98 |
5 |
p. 1275-1285
|
article
|
| 41 |
Subscription Information
|
|
|
|
98 |
5 |
p. A7
|
article
|
| 42 |
Table of Contents
|
|
|
|
98 |
5 |
p. A9, A11, A13, A15, A17
|
article
|
| 43 |
The authors reply
|
Ng, Jia H.
|
|
|
98 |
5 |
p. 1348-1349
|
article
|
| 44 |
The authors reply
|
Paranjpe, Ishan
|
|
|
98 |
5 |
p. 1347-1348
|
article
|
| 45 |
The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis
|
Hassanein, Mohamed
|
|
|
98 |
5 |
p. 1357-1358
|
article
|
| 46 |
The Case | Kidney injury in a patient receiving nivolumab
|
Pichler Sekulic, Simona
|
|
|
98 |
5 |
p. 1359-1360
|
article
|
| 47 |
The ins-and-outs of podocyte lipid metabolism
|
Meyer-Schwesinger, Catherine
|
|
|
98 |
5 |
p. 1087-1090
|
article
|
| 48 |
The potassium regulator patiromer affects serum and stool electrolytes in patients receiving hemodialysis
|
Amdur, Richard L.
|
|
|
98 |
5 |
p. 1331-1340
|
article
|
| 49 |
The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds
|
Jonsson, Arnar J.
|
|
|
98 |
5 |
p. 1286-1295
|
article
|
| 50 |
The transcriptomic signature of the aging podocyte
|
Mukhi, Dhanunjay
|
|
|
98 |
5 |
p. 1079-1081
|
article
|
| 51 |
Thrombomodulin ameliorates transforming growth factor-β1–mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway
|
Takeshita, Atsuro
|
|
|
98 |
5 |
p. 1179-1192
|
article
|
| 52 |
Time-dependent effect, immortal bias, and competing risk: 3 components that should be handled to assess the impact of covariates on occurrence of acute kidney injury
|
Jamme, Matthieu
|
|
|
98 |
5 |
p. 1348
|
article
|
| 53 |
Visualization of sodium dynamics in the kidney by magnetic resonance imaging in a multi-site study
|
Grist, James T.
|
|
|
98 |
5 |
p. 1174-1178
|
article
|
Journal description